ArticleBioinformatics (Oxford, England)2026
Learnable frozen feature augmentation for few-shot biomarker prediction from pathology whole-slide images.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
motivationWhole-slide image (WSI)-based biomarker prediction in computational pathology has the potential to support scalable and resource-efficient analysis of large pathology cohorts, helping prioritize cases for downstream molecular testing and patient stratification. However, reliable biomarker labels are often limited and costly to obtain, making label-efficient WSI prediction essential. Recent slide-level foundation models have opened new opportunities for few-shot biomarker prediction by providing strong pretrained slide representations. Nevertheless, few-shot learning still suffers from sparse labeled support data, and data augmentation remains important for improving robustness and generalization. In frozen multi-stage WSI pipelines, however, conventional augmentation is difficult to apply: pixel-level augmentation requires costly feature re-extraction, while naive perturbation of frozen representations may compromise semantic consistency.
resultsTo address this challenge, we propose Learnable Frozen Feature Augmentation (LFFA), a training-time feature-space augmentation framework for few-shot WSI biomarker prediction. Instead of directly perturbing frozen slide features, LFFA learns controllable augmented slide views from contextualized interaction tokens under geometry-aware and downstream-supervised constraints, improving representation diversity while preserving semantic consistency. The augmented features are further optimized with an augmented-class α-mix loss to balance diversity and class semantics. We evaluate LFFA on three few-shot WSI biomarker prediction tasks, covering molecular marker prediction and gene mutation prediction, using three representative and widely used slide-level foundation models. Results show that LFFA consistently improves the corresponding baselines and achieves stronger overall robustness than existing augmentation methods across tasks, backbones, and shot settings. AVAILABILITY AND IMPLEMENTATION: Source code and processed experimental splits will be made available at https://github.com/zdipath/LFFA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.